Cempra Stock

Cempra Inc: This Announcement Just Crushed CEMP Stock

What Happened to CEMP Stock? Cempra Inc (NASDAQ:CEMP) fell 56% by Thursday afternoon after Cempra's new drug application for its pneumonia medicine was rejected by the U.S. Food and Drug Administration (FDA). The news of the rejection of Solithromycin, an oral and intravenous pneumonia treatment, sent CEMP stock…

Cempra Inc: Why CEMP Stock Is in Total Self-Destruct Mode

What's Up with Cempra's Massive Decline?  Cempra Inc (NASDAQ:CEMP) stock has burned to the ground, dropping 56% today after warnings from the U.S. Food and Drug Administration (FDA) that its experimental drug causes a higher rate of chemically induced liver damage compared to alternative treatments. The FDA report called the…